IM Cannabis Corp. (IMCC)

Market Cap	1.45M -90.6%
Revenue (ttm)	36.47M -6.5%
Net Income	-9.94M
EPS	-2.01
Shares Out	6.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	238,895
Open	0.2424
Previous Close	0.2473
Day's Range	0.2230 - 0.2437
52-Week Range	0.2111 - 3.7500
Beta	1.98
Analysts	Hold
Price Target	5.89 (+2,434.97%)
Earnings Date	May 13, 2026

About IMCC

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1980
• Employees: 44
• Stock Exchange: NASDAQ
• Ticker Symbol: IMCC
• Website: https://imcannabis.com

Financial Performance

In 2025, IM Cannabis's revenue was 54.73 million, an increase of 1.30% compared to the previous year's 54.03 million. Losses were -11.32 million, 6.93% more than in 2024.

Financial numbers in CAD

Analyst Summary

According to one analyst, the rating for IMCC stock is "Hold" and the 12-month stock price target is $5.89.

Price Target

$5.89

(2,434.97% upside)

Analyst Consensus: Hold